Waters Corporation WAT
Set alert
As of Nov 3, 3:04 PM ET
- YTD
- +21.11%
- 1 year
- +33.11%
- Open
- 456.61
- Prev close
- 449.53
- Mkt cap
- 45.17B
- Vol
- 1.26M
- Avg vol
- 825.64K
- EPS
- 3.95
- P/E
- 116.46
- Div yield
- 0.00%
More statistics
- Low
- 449.51
- High
- 474.29
- Forward P/E
- 27.13
- Beta
- 1.15
- Short ratio
- 3.72
- Inst. own
- 102.16%
- Dividend
- 0.00
- Ex-div date
- Nov 25, 1996
- Earnings
- Nov 3, 2026
- 50-d avg
- 430.19
- 200-d avg
- 369.52
- 1y target
- 465.86
1Y chart
Events in this range
- Nov 4, 2025Earnings: 3.4; estimate 3.21; surprise 5.92%
- Feb 9, 2026Earnings: 4.53; estimate 4.51; surprise 0.44%
- May 5, 2026Earnings: 2.7; estimate 2.31; surprise 16.88%
- Aug 4, 2026Earnings: 3.05; estimate 3.01; surprise 1.33%
- Aug 27, 2026Rating: Piper Sandler · Neutral → Overweight
- Sep 9, 2026Rating: UBS · Neutral → Buy
- Sep 21, 2026Rating: Goldman Sachs · Buy → Buy
- Oct 1, 2026Rating: Guggenheim · Buy → Buy
- Oct 7, 2026Rating: Barclays · Overweight → Overweight
- Oct 13, 2026Rating: TD Cowen · Buy → Buy
- Nov 3, 2026Earnings: —; estimate 4; surprise —%
Signals (50)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 28, 2026 | 6 days ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 7, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 4 weeks ago |
| MACD: Sell Signal | Oct 2, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| RSI: Overbought | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 29, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 8, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 30, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| RSI: Overbought | May 29, 2026 | 5 months ago |
| MACD: Buy Signal | May 28, 2026 | 5 months ago |
| SMA: Bullish | May 27, 2026 | 5 months ago |
| SMA: Bearish | May 26, 2026 | 5 months ago |
Newest 20 of 50.
Key statistics
- Market cap
- 44.10B
- Enterprise value
- 50.40B
- Trailing P/E
- 113.70
- Forward P/E
- 27.13
- PEG ratio
- 1.72
- Price / sales
- 9.49
- Price / book
- 2.90
- EPS (TTM)
- 3.95
- Beta
- 1.15
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 3.59%
- Revenue (TTM)
- 4.64B
- Revenue growth
- 113.40%
- Free cash flow
- -142.07M
- Total cash
- 539.00M
- Total debt
- 5.48B
- Return on equity
- 1.92%
- Shares outstanding
- 98.19M
- Short % of float
- 3.25%
- 50-day average
- 430.19
- 200-day average
- 369.52
Analyst view
Consensus: buy
- Target (low)
- 349.00
- Target (mean)
- 465.86
- Target (high)
- 530.00
- Strong buy3
- Buy15
- Hold4
- Sell0
- Strong sell1
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate 4.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Oct 4, 2026 | 4.00 | — | — | — |
| Aug 4, 2026 | Jul 4, 2026 | 3.01 | 3.05 | +0.04 | +1.33% |
| May 5, 2026 | Apr 4, 2026 | 2.31 | 2.70 | +0.39 | +16.88% |
| Feb 9, 2026 | Dec 31, 2025 | 4.51 | 4.53 | +0.02 | +0.44% |
| Nov 4, 2025 | Sep 27, 2025 | 3.21 | 3.40 | +0.19 | +5.92% |
| Aug 4, 2025 | Jun 28, 2025 | 2.94 | 2.95 | +0.01 | +0.34% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | main | Buy | Buy |
| Oct 7, 2026 | Barclays | main | Overweight | Overweight |
| Oct 1, 2026 | Guggenheim | main | Buy | Buy |
| Sep 21, 2026 | Goldman Sachs | main | Buy | Buy |
| Sep 9, 2026 | UBS | up | Neutral | Buy |
| Aug 27, 2026 | Piper Sandler | up | Neutral | Overweight |
About Waters Corporation
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Website
- waters.com
News
- Waters Q3 Earnings & Revenues Beat Estimates, 2026 Guidance Raised
- Waters CEO Says AI Is Already Fueling Lab Demand As Drugmakers Race to Accelerate Discovery
- Waters Corporation (WAT) Q3 2026 Earnings Call Transcript
- Waters (WAT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- Waters Q3 2026 Earnings Call Transcript
- Waters (WAT) Beats Q3 Earnings and Revenue Estimates
- Waters Sees Q4 Adj EPS $4.58-$4.68 vs $4.67 Est; Sees Sales $1.801B-$1.819B vs $1.789B Est
- Waters Q3 Adj. EPS $4.10 Beats $4.00 Estimate, Sales $1.767B Beat $1.754B Estimate
- Waters Raises FY2026 Adj EPS Guidance from $14.45-$14.65 to $14.60-$14.70 vs $14.58 Est; Raises FY2026 Sales Guidance from $6.415B-$6.476B to $6.479B-$6.497B vs $6.456B Est
- Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results
Your note
Sign in to keep a note on WAT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BATRA UDIT | Chief Executive Officer | Stock Award(Grant) | Feb 24, 2026 | 36,557 |
| BENNETT JIANQING | Officer | Stock Award(Grant) | Feb 24, 2026 | 7,244 |
| CARPIO ROBERT L III | Officer | Stock Award(Grant) | Feb 24, 2026 | 3,615 |
| CHAUBAL AMOL | Chief Financial Officer | Stock Award(Grant) | Feb 24, 2026 | 8,505 |
| FEARON RICHARD H | Director | Purchase | Mar 5, 2026 | 3,302 |
| HUANG PEARL S. | Director | Stock Award(Grant) | Feb 24, 2026 | 3,276 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.64% | 8,484,939 | 3.81B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.53% | 6,415,552 | 2.88B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.83% | 4,740,524 | 2.13B | Jun 29, 2026 |
| Massachusetts Financial Services Co. | 4.71% | 4,625,035 | 2.08B | Jun 29, 2026 |
| State Street Corporation | 4.46% | 4,382,008 | 1.97B | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 3.89% | 3,817,779 | 1.71B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 3,116,340 | 1.40B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 2,545,419 | 1.14B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.17% | 2,127,547 | 955.50M | Jun 29, 2026 |
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 2.14% | 2,101,625 | 943.86M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 1,309,174 | 587.96M | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.30% | 1,274,542 | 572.41M | Aug 30, 2026 |